Literature DB >> 19146951

PKCdelta survival signaling in cells containing an activated p21Ras protein requires PDK1.

Shuhua Xia1, Zhihong Chen, Lora W Forman, Douglas V Faller.   

Abstract

Protein kinase C delta (PKCdelta) modulates cell survival and apoptosis in diverse cellular systems. We recently reported that PKCdelta functions as a critical anti-apoptotic signal transducer in cells containing activated p21(Ras) and results in the activation of AKT, thereby promoting cell survival. How PKCdelta is regulated by p21(Ras), however, remains incompletely understood. In this study, we show that PKCdelta, as a transducer of anti-apoptotic signals, is activated by phosphotidylinositol 3' kinase/phosphoinositide-dependent kinase 1 (PI(3)K-PDK1) to deliver the survival signal to Akt in the environment of activated p21(Ras). PDK1 is upregulated in cells containing an activated p21Ras. Knock-down of PDK1, PKCdelta, or AKT forces cells containing activated p21(Ras) to undergo apoptosis. PDK1 regulates PKCdelta activity, and constitutive expression of PDK1 increases PKCdelta activity in different cell types. Conversely, expression of a kinase-dead (dominant-negative) PDK1 significantly suppresses PKCdelta activity. p21(Ras)-mediated survival signaling is therefore regulated by via a PI(3)K-AKT pathway, which is dependent upon both PDK1 and PKCdelta, and PDK1 activates and regulates PKCdelta to determine the fate of cells containing a mutated, activated p21(Ras).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19146951      PMCID: PMC2644428          DOI: 10.1016/j.cellsig.2008.12.002

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  47 in total

Review 1.  Oncogenic kinase signalling.

Authors:  P Blume-Jensen; T Hunter
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

Review 2.  Understanding Ras: 'it ain't over 'til it's over'.

Authors:  J M Shields; K Pruitt; A McFall; A Shaub; C J Der
Journal:  Trends Cell Biol       Date:  2000-04       Impact factor: 20.808

3.  The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells.

Authors:  M R Williams; J S Arthur; A Balendran; J van der Kaay; V Poli; P Cohen; D R Alessi
Journal:  Curr Biol       Date:  2000-04-20       Impact factor: 10.834

Review 4.  Protein kinase C isozymes and substrates in mammary carcinogenesis.

Authors:  S C Kiley; J Welsh; C J Narvaez; S Jaken
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-04       Impact factor: 2.673

5.  Mechanism of phosphorylation of protein kinase B/Akt by a constitutively active 3-phosphoinositide-dependent protein kinase-1.

Authors:  M J Wick; L Q Dong; R A Riojas; F J Ramos; F Liu
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

6.  Further evidence that 3-phosphoinositide-dependent protein kinase-1 (PDK1) is required for the stability and phosphorylation of protein kinase C (PKC) isoforms.

Authors:  A Balendran; G R Hare; A Kieloch; M R Williams; D R Alessi
Journal:  FEBS Lett       Date:  2000-11-10       Impact factor: 4.124

7.  Divergence in the anti-apoptotic signalling pathways used by nerve growth factor and basic fibroblast growth factor (bFGF) in PC12 cells: rescue by bFGF involves protein kinase C delta.

Authors:  M M Wert; H C Palfrey
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

8.  Oncogenic ras mediates apoptosis in response to protein kinase C inhibition through the generation of reactive oxygen species.

Authors:  J S Liou; C Y Chen; J S Chen; D V Faller
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

9.  Protein kinase Calpha and protein kinase Cdelta play opposite roles in the proliferation and apoptosis of glioma cells.

Authors:  R Mandil; E Ashkenazi; M Blass; I Kronfeld; G Kazimirsky; G Rosenthal; F Umansky; P S Lorenzo; P M Blumberg; C Brodie
Journal:  Cancer Res       Date:  2001-06-01       Impact factor: 12.701

Review 10.  The PI3K-PDK1 connection: more than just a road to PKB.

Authors:  B Vanhaesebroeck; D R Alessi
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

View more
  18 in total

1.  Dying tumor cells stimulate proliferation of living tumor cells via caspase-dependent protein kinase Cδ activation in pancreatic ductal adenocarcinoma.

Authors:  Jin Cheng; Ling Tian; Jingjing Ma; Yanping Gong; Zhengxiang Zhang; Zhiwei Chen; Bing Xu; Hui Xiong; Chuanyuan Li; Qian Huang
Journal:  Mol Oncol       Date:  2014-08-07       Impact factor: 6.603

2.  Protein kinase Cδ is a therapeutic target in malignant melanoma with NRAS mutation.

Authors:  Asami Takashima; Brandon English; Zhihong Chen; Juxiang Cao; Rutao Cui; Robert M Williams; Douglas V Faller
Journal:  ACS Chem Biol       Date:  2014-02-18       Impact factor: 5.100

3.  The influence of the total flavonoids of Hedysarum polybotry on the proliferation, cell cycle, and expressions of p21Ras and proliferating cell nuclear antigen gene in erythroleukemia cell line K562.

Authors:  Ya-li Wang; Ya-li Luo; Che Chen; Neng-lian Li; Ya-li She; Li Zhang
Journal:  Chin J Integr Med       Date:  2012-01-12       Impact factor: 1.978

4.  Protein Kinase Cδ Suppresses Autophagy to Induce Kidney Cell Apoptosis in Cisplatin Nephrotoxicity.

Authors:  Dongshan Zhang; Jian Pan; Xudong Xiang; Yu Liu; Guie Dong; Man J Livingston; Jian-Kang Chen; Xiao-Ming Yin; Zheng Dong
Journal:  J Am Soc Nephrol       Date:  2016-10-31       Impact factor: 10.121

Review 5.  Multifunctional roles of PKCδ: Opportunities for targeted therapy in human disease.

Authors:  Mary E Reyland; David N M Jones
Journal:  Pharmacol Ther       Date:  2016-05-11       Impact factor: 12.310

6.  Protein kinase C δ is a downstream effector of oncogenic K-ras in lung tumors.

Authors:  Jennifer M Symonds; Angela M Ohm; Cristan J Carter; Lynn E Heasley; Theresa A Boyle; Wilbur A Franklin; Mary E Reyland
Journal:  Cancer Res       Date:  2011-02-18       Impact factor: 12.701

7.  Protein kinase Cδ inactivation inhibits cellular proliferation and decreases survival in human neuroendocrine tumors.

Authors:  Zhihong Chen; Lora W Forman; Kenneth A Miller; Brandon English; Asami Takashima; Regine A Bohacek; Robert M Williams; Douglas V Faller
Journal:  Endocr Relat Cancer       Date:  2011-12-01       Impact factor: 5.678

8.  Antitumor mechanisms of targeting the PDK1 pathway in head and neck cancer.

Authors:  Neil E Bhola; Maria L Freilino; Sonali C Joyce; Malabika Sen; Sufi M Thomas; Anirban Sahu; Andre Cassell; Ching-Shih Chen; Jennifer R Grandis
Journal:  Mol Cancer Ther       Date:  2012-04-05       Impact factor: 6.261

Review 9.  Targeting the RAS oncogene.

Authors:  Asami Takashima; Douglas V Faller
Journal:  Expert Opin Ther Targets       Date:  2013-01-30       Impact factor: 6.902

10.  BSTA promotes mTORC2-mediated phosphorylation of Akt1 to suppress expression of FoxC2 and stimulate adipocyte differentiation.

Authors:  Yixin Yao; Milind Suraokar; Bryant G Darnay; Brett G Hollier; Tattym E Shaiken; Takayuki Asano; Chien-Hung Chen; Benny H-J Chang; Yiling Lu; Gordon B Mills; Dos Sarbassov; Sendurai A Mani; James L Abbruzzese; Shrikanth A G Reddy
Journal:  Sci Signal       Date:  2013-01-08       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.